Literature DB >> 2173676

c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.

L Keatings1, J Sinclair, C Wright, I P Corbett, C Watchorn, C Hennessy, B Angus, T Lennard, C H Horne.   

Abstract

Over-expression of the c-erbB-2 oncogene occurs in a proportion of human adenocarcinomas and in breast carcinoma is associated with poorer prognosis. Sections of formalin-fixed, paraffin-embedded tumour tissue from 22 patients with mammary and extramammary Paget's disease have been stained immunohistochemically using a monoclonal antibody (NCL-CB11) raised against a synthetic peptide from the C-terminal end of the predicted sequence of the c-erbB-2 protein product. All 12 cases of mammary Paget's disease showed membrane staining of intra-epidermal cells, indicating c-erbB-2 over-expression. Sections of underlying ductal breast carcinoma were available in nine cases; all nine tumours were c-erbB-2 positive and in eight the in situ component was of comedo or solid type. There was membrane staining of tumour cells in four of the 10 cases of extramammary Paget's disease; staining intensity was generally weaker than that observed in the cases of mammary disease. The possible implications of these findings for the histogenesis of both mammary and extramammary Paget's disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173676     DOI: 10.1111/j.1365-2559.1990.tb00714.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

Review 1.  Mammary and extramammary Paget's disease.

Authors:  J Lloyd; A M Flanagan
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Lack of c-erbB-2 oncoprotein expression in male breast carcinoma.

Authors:  S B Fox; C A Day; S Rogers
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

3.  Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.

Authors:  D N Poller; M Galea; D Pearson; J Bell; W J Gullick; C W Elston; R W Blamey; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

4.  c-erbB-2 expression in different histological types of invasive breast carcinoma.

Authors:  S Soomro; S Shousha; P Taylor; H M Shepard; M Feldmann
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

5.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

6.  Proliferating activity in paget disease of the nipple.

Authors:  Jean-Christophe Noel; Isabelle Fayt; Frederic Buxant
Journal:  Pathol Oncol Res       Date:  2009-12-17       Impact factor: 3.201

7.  The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer.

Authors:  I Brotherick; B K Shenton; W K Cowan; B Angus; C H Horne; M J Higgs; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

8.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

9.  Paget's disease of the breast.

Authors:  Cansu Karakas
Journal:  J Carcinog       Date:  2011-12-08

10.  A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy.

Authors:  Fumie Hanawa; Takashi Inozume; Kazutoshi Harada; Tatsuyosi Kawamura; Naotaka Shibagaki; Shinji Shimada
Journal:  Case Rep Dermatol       Date:  2011-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.